Professor Sun Myint
Clatterbridge Cancer Centre (Private Clinic)
Professor Sun Myint introduced Papillon in 1993 and established the first facility in the UK at Clatterbridge Cancer Centre. He has now treated over 1600 patients with Papillon which is the world largest cohort treated by non-surgical method. He collaborated with his mentor Prof Jean Pierre Gerard (Nice) and Ariane a British company to produce a new contact X-ray machine. Since 2009 he used the first prototype Papillon 50. He is now working closely with Ariane to produce a second generation Papillon Plus machine which can treat other tumour sites such as breast, skin, eye, intra oral, intra vagina and intra operative radiation therapy.
NICE has now approved the Papillon treatment for rectal cancer in patients not suitable for surgery (IPG 532). For his contributions to oncology, he was awarded Honorary Professor by University of Liverpool in 2012. He led the UK Papillon team which won the prestigious BMJ award for ‘Cancer team of the year’ in May 2018.
Rectal cancer- Do patients have a choice?
Each year 12,000 patients are diagnosed with rectal cancer in the UK. The standard of care is radical surgery. Not all patients are suitable for surgery due to advancing age and their comorbidities. The mortality and morbidity is high following surgery in elderly patients. There is increase in ageing population in the UK. Contact X-ray brachytherapy[CXB] (Papillon) will be discuss as an alternative non-surgical treatment option for patients not suitable for surgery.
EVEN MORE SEMINARS
Dr Ndaba Mazibuko Care Oncology Clinic, Kings College London
Drug Repurposing In Practice: Metabolic Pleiotropism in Glioblastoma Management
Michael Schreiber Brain Tumor Foundation, Chairman
Brain Tumors - Innovation, support and advocacy
Chris Curtis The Swallows Head & Neck Cancer Charity
A patient’s journey ‘Cancer to the palace in 6yrs’
Profess Liz Ward Centre for Functioning and Health Research, Metro South Hospital and Health Service, and The Univers
Laryngectomy rehabilitation: Opportunities for improving speech pathology supports via telehealth
Glenn Flux Royal Marsden Hospital
The emergence and resurgence of radiotherapeutics for cancer treatment